Annika Ålgars
Impact in
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Inflammatory Biomarkers in Disease Prognosis
- Physiology top 10%
Papers in
- Oncology 27
- Colorectal Cancer Treatments and Studies 18
- Colorectal Cancer Surgical Treatments 4
- Colorectal Cancer Screening and Detection 3
-
- Gastric Cancer Management and Outcomes 9
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Raija Ristamäki (25 shared papers)Jari Sundström (14 shared papers)Sirpa Jalkanen (4 shared papers)Olli Carpén (11 shared papers)Heikki Irjala (3 shared papers)Marko Salmi (2 shared papers)Minnamaija Lintunen (7 shared papers)Heikki Huhtinen (3 shared papers)
In The Last Decade
Annika Ålgars
30 papers receiving 650 citations
Peers
Comparison fields: 5 of 72
- Oncology 393
- Physiology 46
- Immunology 185
- Cancer Research 111
- Gastroenterology 33
Countries citing papers authored by Annika Ålgars
This map shows the geographic impact of Annika Ålgars's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annika Ålgars with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annika Ålgars more than expected).
Fields of papers citing papers by Annika Ålgars
This network shows the impact of papers produced by Annika Ålgars. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annika Ålgars. The network helps show where Annika Ålgars may publish in the future.
Co-authors
The 25 scholars most cited alongside Annika Ålgars, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 125 | |
| 2 | 2013 | 62 | |
| 3 | 2011 | 62 | |
| 4 | 2015 | 54 | |
| 5 | 2017 | 51 | |
| 6 | 2011 | 40 | |
| 7 | 2006 | 30 | |
| 8 | 2021 | 27 | |
| 9 | 2021 | 25 | |
| 10 | 2020 | 23 | |
| 11 | 2016 | 23 | |
| 12 | 2016 | 22 | |
| 13 | 2014 | 17 | |
| 14 | 2008 | 16 | |
| 15 | Nuclear size as prognostic determinant in stage II and stage III colorectal adenocarcinoma. | 2006 | 13 |
| 16 | 2004 | 12 | |
| 17 | 2021 | 9 | |
| 18 | 2006 | 7 | |
| 19 | 2006 | 7 | |
| 20 | 2017 | 7 |
About Annika Ålgars
Annika Ålgars is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Cancer Research and Surgery, having authored 34 papers that have together received 657 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (18 papers), Genetic factors in colorectal cancer (12 papers), Gastric Cancer Management and Outcomes (9 papers), Cancer Genomics and Diagnostics (7 papers), Colorectal Cancer Surgical Treatments (4 papers), Lung Cancer Treatments and Mutations (4 papers), Gastrointestinal Tumor Research and Treatment (3 papers) and Colorectal Cancer Screening and Detection (3 papers). The work is most often cited by research in Oncology (393 citations), Physiology (46 citations), Immunology (185 citations), Cancer Research (111 citations) and Gastroenterology (33 citations). Annika Ålgars has collaborated with scholars based in Finland, Sweden and Norway. Frequent co-authors include Raija Ristamäki, Jari Sundström, Sirpa Jalkanen, Olli Carpén, Heikki Irjala, Marko Salmi, Minnamaija Lintunen, Heikki Huhtinen, Samuli Vaittinen and Yrjö Collan. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Acta Oncologica, British Journal of Cancer and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.